BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 007686
(593 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 36.2 bits (82), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 142 GQVYKAQLKYSGQIVAVK-VQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VYKA+ +SG VA+K V+ P EE GL +R V L+ + +VV L+D
Sbjct: 18 GTVYKARDPHSGHFVALKSVRVPNGEE--GLPISTVREVA-LLRRLEAFEHPNVVRLMDV 74
Query: 201 FA-SRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNEQ 259
A SR +E+ ++ + + Y DK P + K L +++ G+
Sbjct: 75 CATSRTDREIKVTLVFEHVDQDLRTYLDK----APPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 260 VAI--ENPHPGNLLATPEGKLAFLDFGM 285
I + P N+L T G + DFG+
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGL 158
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 36.2 bits (82), Expect = 0.060, Method: Compositional matrix adjust.
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 142 GQVYKAQLKYSGQIVAVK-VQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VYKA+ +SG VA+K V+ P EE GL +R V L+ + +VV L+D
Sbjct: 18 GTVYKARDPHSGHFVALKSVRVPNGEE--GLPISTVREVA-LLRRLEAFEHPNVVRLMDV 74
Query: 201 FA-SRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNEQ 259
A SR +E+ ++ + + Y DK P + K L +++ G+
Sbjct: 75 CATSRTDREIKVTLVFEHVDQDLRTYLDK----APPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 260 VAI--ENPHPGNLLATPEGKLAFLDFGM 285
I + P N+L T G + DFG+
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGL 158
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 35.8 bits (81), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 142 GQVYKAQLKYSGQIVAVK-VQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VYKA+ +SG VA+K V+ P EE GL +R V L+ + +VV L+D
Sbjct: 18 GTVYKARDPHSGHFVALKSVRVPNGEE--GLPISTVREVA-LLRRLEAFEHPNVVRLMDV 74
Query: 201 FA-SRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNEQ 259
A SR +E+ ++ + + Y DK P + K L +++ G+
Sbjct: 75 CATSRTDREIKVTLVFEHVDQDLRTYLDK----APPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 260 VAI--ENPHPGNLLATPEGKLAFLDFGM 285
I + P N+L T G + DFG+
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGL 158
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 34.7 bits (78), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 43/161 (26%), Positives = 64/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 21 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 76
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 77 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 127
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R A+ G
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCG 168
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 34.3 bits (77), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 43/161 (26%), Positives = 64/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 24 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 79
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 80 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 130
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R A+ G
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCG 171
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 33.5 bits (75), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 64/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 21 FGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 76
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F ++RVY L Y G R +KL E T+ + + ++
Sbjct: 77 FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 127
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R A+ G
Sbjct: 128 KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCG 168
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 33.5 bits (75), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 42/185 (22%), Positives = 76/185 (41%), Gaps = 23/185 (12%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDEF 201
G V K K SGQI+AVK R ++E L++ V + ++D ++ +
Sbjct: 36 GSVNKMVHKPSGQIMAVKRIRSTVDEK--------EQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 202 ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVL--TMEWVEGVKLNEQ 259
+ + ++ + F K Y VL D+ + GK+ T++ + +K N +
Sbjct: 88 GALFREGDCWICMELMSTSFDKFYKYVYSVL-DDVIPEEILGKITLATVKALNHLKENLK 146
Query: 260 VAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIGHVVHMVNRDYEAMARDYYAL 319
+ + P N+L G + DFG I G +V + + +A R Y A
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFG------------ISGQLVDSIAKTRDAGCRPYMAP 194
Query: 320 DFLSP 324
+ + P
Sbjct: 195 ERIDP 199
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 33.5 bits (75), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 64/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 26 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 81
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G+ + +KL E T+ + + ++
Sbjct: 82 FHDATRVYLILEYAPRGEVYKELQKLSKFDEQ---------RTATYITELANALSYCHSK 132
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 173
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 33.1 bits (74), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 20 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 75
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 76 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 126
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 127 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 167
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 33.1 bits (74), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 21 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 76
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 77 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 127
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCG 168
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 33.1 bits (74), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 24 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 79
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 80 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 130
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCG 171
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 33.1 bits (74), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 24 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 79
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 80 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 130
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 171
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 33.1 bits (74), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 21 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 76
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 77 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 127
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 168
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 32.7 bits (73), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 21 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 76
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 77 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 127
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCG 168
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 32.7 bits (73), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 25 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 80
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 81 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 131
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 132 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 172
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 32.7 bits (73), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 24 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 79
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 80 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 130
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 171
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 32.7 bits (73), Expect = 0.58, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 23 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 78
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 79 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 129
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCG 170
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 32.7 bits (73), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 26 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 81
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 82 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 132
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 173
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 32.7 bits (73), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 64/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 26 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 81
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G+ + +KL E T+ + + ++
Sbjct: 82 FHDATRVYLILEYAPRGEVYKELQKLSKFDEQ---------RTATYITELANALSYCHSK 132
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXG 173
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 32.7 bits (73), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 22 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 77
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 128
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSG 169
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 32.3 bits (72), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 26 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 81
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 82 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 132
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 173
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 32.3 bits (72), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 22 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 77
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 128
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCG 169
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 32.3 bits (72), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 21 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 76
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 77 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 127
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCG 168
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 32.3 bits (72), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 22 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 77
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 128
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG 169
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 32.3 bits (72), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 21 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 76
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 77 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 127
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG 168
>pdb|3E2Z|B Chain B, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii In Complex With Kynurenine
pdb|3E2Y|A Chain A, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii In Complex With Glutamine
pdb|3E2Y|B Chain B, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii In Complex With Glutamine
Length = 410
Score = 32.3 bits (72), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 19/35 (54%), Positives = 23/35 (65%), Gaps = 6/35 (17%)
Query: 68 FTRLG--PTFVKLGQGLSTRPDICPPEYL-EELSE 99
FT+L P+ V LGQG PDI PP Y+ EELS+
Sbjct: 16 FTKLAADPSVVNLGQGF---PDISPPSYVKEELSK 47
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 32.3 bits (72), Expect = 0.84, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 21 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 76
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 77 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 127
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG 168
>pdb|3E2F|A Chain A, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii, Plp-Bound Form
pdb|3E2F|B Chain B, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii, Plp-Bound Form
pdb|3E2Z|A Chain A, Crystal Structure Of Mouse Kynurenine Aminotransferase
Iii In Complex With Kynurenine
pdb|2ZJG|A Chain A, Crystal Structural Of Mouse Kynurenine Aminotransferase
Iii
pdb|2ZJG|B Chain B, Crystal Structural Of Mouse Kynurenine Aminotransferase
Iii
Length = 410
Score = 32.3 bits (72), Expect = 0.86, Method: Compositional matrix adjust.
Identities = 19/35 (54%), Positives = 23/35 (65%), Gaps = 6/35 (17%)
Query: 68 FTRLG--PTFVKLGQGLSTRPDICPPEYL-EELSE 99
FT+L P+ V LGQG PDI PP Y+ EELS+
Sbjct: 16 FTKLAADPSVVNLGQGF---PDISPPSYVKEELSK 47
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 32.0 bits (71), Expect = 0.91, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 38 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 93
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 94 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 144
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 145 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 185
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 32.0 bits (71), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 47 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 102
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 153
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 194
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 32.0 bits (71), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 26 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 81
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 82 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 132
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG 173
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 31.6 bits (70), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 24 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 79
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 80 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 130
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCG 171
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 31.6 bits (70), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ + S I+A+KV E G++ L R V + + +++ L
Sbjct: 25 FGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 80
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 81 FHDATRVYLILEYAPLGTVYRELQKLSRFDEQ---------RTATYITELANALSYCHSK 131
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCG 172
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 31.2 bits (69), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 24 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 79
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 80 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 130
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L +FG P R + G
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCG 171
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 31.2 bits (69), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 62/161 (38%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K I+A+KV E G++ L R V + + +++ L
Sbjct: 18 FGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 73
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 74 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 124
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 125 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 165
>pdb|3ILK|A Chain A, The Structure Of A Probable Methylase Family Protein From
Haemophilus Influenzae Rd Kw20
pdb|3ILK|B Chain B, The Structure Of A Probable Methylase Family Protein From
Haemophilus Influenzae Rd Kw20
Length = 244
Score = 31.2 bits (69), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 13/35 (37%), Positives = 21/35 (60%)
Query: 191 TTDVVALIDEFASRVYQELNYVQEGQNARRFKKLY 225
TTD +A ++ R+YQ L ++Q R+ K+LY
Sbjct: 179 TTDQLAYFFDYTERIYQSLGFIQNQGVXRKLKRLY 213
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 30.8 bits (68), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ + S I+A+KV E G++ L R V + + +++ L
Sbjct: 25 FGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 80
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 81 FHDATRVYLILEYAPLGTVYRELQKLSRFDEQ---------RTATYITELANALSYCHSK 131
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCG 172
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 30.8 bits (68), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 23 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 78
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 79 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 129
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L +FG P R + G
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCG 170
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 30.8 bits (68), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 15/146 (10%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDEF 201
G VYKA+ K +G++VA+K R E G+ IR + L ++ ++V L+D
Sbjct: 20 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLL----KELNHPNIVKLLDVI 74
Query: 202 ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKL--NEQ 259
+ L + Q+ ++F A + +P I K + ++G+ + +
Sbjct: 75 HTENKLYLVFEHVDQDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGLAFCHSHR 126
Query: 260 VAIENPHPGNLLATPEGKLAFLDFGM 285
V + P NLL EG + DFG+
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGL 152
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 30.4 bits (67), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 141 LGQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDE 200
G VY A+ K S I+A+KV E G++ L R V + + +++ L
Sbjct: 47 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGY 102
Query: 201 F--ASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
F A+RVY L Y G R +KL E T+ + + ++
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---------RTATYITELANALSYCHSK 153
Query: 259 QVAIENPHPGNLLATPEGKLAFLDFGMMSETPEEARFAIIG 299
+V + P NLL G+L DFG P R + G
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCG 194
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 30.4 bits (67), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 17 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 74
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 75 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 116
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 117 SFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 30.4 bits (67), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 17 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 74
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 75 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 116
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 30.4 bits (67), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 16 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 73
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 74 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 115
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 148
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 30.4 bits (67), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 142 GQVYKAQ-LKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITT-DVVALID 199
G+V+KA+ LK G+ VA+K R E G+ IR V L ++++ +VV L D
Sbjct: 25 GKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVL--RHLETFEHPNVVRLFD 81
Query: 200 EFA-SRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKL-- 256
SR +E ++ + Y DK VP+ + K + + + G+
Sbjct: 82 VCTVSRTDRETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 257 NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P N+L T G++ DFG+
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGL 166
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 30.4 bits (67), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 18/62 (29%), Positives = 30/62 (48%), Gaps = 6/62 (9%)
Query: 267 PGNLLATPEGKLAFLDFGMMSET--PEEARFAIIGHVVHM----VNRDYEAMARDYYALD 320
P N+L EG + DFG+ E+ E+ ++ G V +M VNR + D+++
Sbjct: 154 PENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG 213
Query: 321 FL 322
L
Sbjct: 214 VL 215
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 30.4 bits (67), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 18/62 (29%), Positives = 30/62 (48%), Gaps = 6/62 (9%)
Query: 267 PGNLLATPEGKLAFLDFGMMSET--PEEARFAIIGHVVHM----VNRDYEAMARDYYALD 320
P N+L EG + DFG+ E+ E+ ++ G V +M VNR + D+++
Sbjct: 155 PENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG 214
Query: 321 FL 322
L
Sbjct: 215 VL 216
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 30.0 bits (66), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 17 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 74
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 75 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 116
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 30.0 bits (66), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 16 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 73
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 74 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 115
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 148
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 30.0 bits (66), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 21 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 78
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 79 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 120
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 121 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 153
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 30.0 bits (66), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 19 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 76
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 77 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 118
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 151
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 30.0 bits (66), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 18 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 75
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 76 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 117
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 150
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 30.0 bits (66), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 17 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 74
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 75 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 116
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 30.0 bits (66), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 18/62 (29%), Positives = 30/62 (48%), Gaps = 6/62 (9%)
Query: 267 PGNLLATPEGKLAFLDFGMMSET--PEEARFAIIGHVVHM----VNRDYEAMARDYYALD 320
P N+L EG + DFG+ E+ E+ ++ G V +M VNR + D+++
Sbjct: 154 PENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG 213
Query: 321 FL 322
L
Sbjct: 214 VL 215
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 30.0 bits (66), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 17 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 74
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 75 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 116
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 30.0 bits (66), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 35/146 (23%), Positives = 65/146 (44%), Gaps = 17/146 (11%)
Query: 144 VYKAQLKYSGQIVAVKVQRPG--IEEAIGLDFYLIRGVGFLINKYVDIITTDVVALIDEF 201
VYKA+ K + QIVA+K + G E G++ +R + L ++ +++ L+D F
Sbjct: 26 VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL----QELSHPNIIGLLDAF 81
Query: 202 A--SRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNEQ 259
S + ++++ + + D VL P Y ++T++ +E +
Sbjct: 82 GHKSNISLVFDFMETD-----LEVIIKDNSLVLTPSHIKAYM---LMTLQGLEYLH-QHW 132
Query: 260 VAIENPHPGNLLATPEGKLAFLDFGM 285
+ + P NLL G L DFG+
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGL 158
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 30.0 bits (66), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 16 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 73
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 74 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 115
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 148
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 30.0 bits (66), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 17 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 74
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 75 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 116
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 30.0 bits (66), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 18 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 75
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 76 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 117
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 150
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 30.0 bits (66), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 17 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 74
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 75 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 116
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 30.0 bits (66), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 17 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 74
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 75 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 116
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 30.0 bits (66), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 142 GQVYKAQ-LKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITT-DVVALID 199
G+V+KA+ LK G+ VA+K R E G+ IR V L ++++ +VV L D
Sbjct: 25 GKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVL--RHLETFEHPNVVRLFD 81
Query: 200 EFA-SRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKL-- 256
SR +E ++ + Y DK VP+ + K + + + G+
Sbjct: 82 VCTVSRTDRETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 257 NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P N+L T G++ DFG+
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGL 166
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 30.0 bits (66), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 21 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 78
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 79 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 120
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 121 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 153
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 30.0 bits (66), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 20 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 77
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 78 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 119
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 152
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 30.0 bits (66), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 19 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 76
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 77 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 118
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 151
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 30.0 bits (66), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 24 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 81
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 82 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 123
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 124 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 156
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 30.0 bits (66), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 16 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 73
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 74 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 115
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 148
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 30.0 bits (66), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 19 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 76
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 77 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 118
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 119 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGL 151
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 30.0 bits (66), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 18 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 75
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 76 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 117
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 150
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 30.0 bits (66), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 16 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 73
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y +V Q+ + F A + +P I K + ++G+
Sbjct: 74 --------NKLYLVFEHVH--QDLKTFMDASA-LTGIPLPLI-------KSYLFQLLQGL 115
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 148
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 30.0 bits (66), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 24 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 81
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 82 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 123
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 124 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 156
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 30.0 bits (66), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 20 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 77
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 78 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 119
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 152
>pdb|3JVN|A Chain A, Crystal Structure Of The Acetyltransferase Vf_1542 From
Vibrio Fischeri, Northeast Structural Genomics
Consortium Target Vfr136
Length = 166
Score = 29.6 bits (65), Expect = 4.4, Method: Composition-based stats.
Identities = 20/85 (23%), Positives = 39/85 (45%), Gaps = 6/85 (7%)
Query: 179 VGFLINKYVDIITTDVVALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIF- 237
+GF+ + ++I+T + +Y E Y +EG + ++ + +D V +IF
Sbjct: 68 IGFITGHFCELISTVSKLVXXATIDELYIEKEYRREGVAEQLXXRIEQELKDYGVKEIFV 127
Query: 238 --WDYTSGKVLTMEWVEGVKLNEQV 260
WD+ G +E+ LNE +
Sbjct: 128 EVWDFNKG---ALEFYNKQGLNEHI 149
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 29.6 bits (65), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 18 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 75
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ ++F A + +P I K + ++G+
Sbjct: 76 --------NKLYLVFEFLH--QDLKKFMDASA-LTGIPLPLI-------KSYLFQLLQGL 117
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGL 150
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 29.6 bits (65), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 142 GQVYKAQ-LKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFLINKYVDIITT-DVVALID 199
G+V+KA+ LK G+ VA+K R E G+ IR V L ++++ +VV L D
Sbjct: 25 GKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVL--RHLETFEHPNVVRLFD 81
Query: 200 EFA-SRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKL-- 256
SR +E ++ + Y DK VP+ + K + + + G+
Sbjct: 82 VCTVSRTDRETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 257 NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P N+L T G++ DFG+
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGL 166
>pdb|2I2P|O Chain O, Crystal Structure Of Ribosome With Messenger Rna And The
Anticodon Stem-Loop Of P-Site Trna. This File Contains
The 30s Subunit Of One 70s Ribosome. The Entire Crystal
Structure Contains Two 70s Ribosomes And Is Described
In Remark 400.
pdb|2I2U|O Chain O, Crystal Structure Of Ribosome With Messenger Rna And The
Anticodon Stem-Loop Of P-Site Trna. This File Contains
The 30s Subunit Of One 70s Ribosome. The Entire Crystal
Structure Contains Two 70s Ribosomes And Is Described
In Remark 400.
pdb|3FIH|O Chain O, Ternary Complex-Bound E.Coli 70s Ribosome. This Entry
Consists Of The 30s Subunit, Trnas And The Ternary
Complex.
pdb|3IY8|O Chain O, Leishmania Tarentolae Mitonchondrial Ribosome Small
Subunit
pdb|2WWL|O Chain O, E.Coli 70s Ribosome Stalled During Translation Of Tnac
Leader Peptide. This File Contains The 30s, The P-Site
Trna And The Tnac Leader Peptide (Part 1 Of 2).
pdb|3J00|O Chain O, Structure Of The Ribosome-Secye Complex In The Membrane
Environment
pdb|4A2I|O Chain O, Cryo-Electron Microscopy Structure Of The 30s Subunit In
Complex With The Yjeq Biogenesis Factor
pdb|3J0U|R Chain R, Structural Characterization Of Mrna-Trna Translocation
Intermediates (30s Ribosome Of Class2 Of The Six
Classes)
pdb|3J0V|R Chain R, Structural Characterization Of Mrna-Trna Translocation
Intermediates (30s Ribosome Of Class 4a Of The Six
Classes)
pdb|3J0X|R Chain R, Structural Characterization Of Mrna-Trna Translocation
Intermediates (30s Ribosome Of Class 4b Of The Six
Classes)
pdb|3J0Z|R Chain R, Structural Characterization Of Mrna-Trna Translocation
Intermediates (30s Ribosome Of Class 5 Of The Six
Classes)
pdb|3J10|R Chain R, Structural Characterization Of Mrna-Trna Translocation
Intermediates (30s Ribosome Of Class 6 Of The Six
Classes)
pdb|3J13|Q Chain Q, Structural Characterization Of Mrna-Trna Translocation
Intermediates (30s Ribosome Of Class 3 Of The Six
Classes)
Length = 88
Score = 29.6 bits (65), Expect = 5.4, Method: Composition-based stats.
Identities = 23/68 (33%), Positives = 30/68 (44%), Gaps = 11/68 (16%)
Query: 16 ARNYGSRPVQLLRRTLQILVALGSFS-----------LKLLIDQRNGVLDQNKRKRAAEL 64
A + GS VQ+ T QI G F+ L ++ QR +LD KRK A
Sbjct: 18 ANDTGSTEVQVALLTAQINHLQGHFAEHKKDHHSRRGLLRMVSQRRKLLDYLKRKDVARY 77
Query: 65 RRIFTRLG 72
R+ RLG
Sbjct: 78 TRLIERLG 85
>pdb|2AVY|O Chain O, Crystal Structure Of The Bacterial Ribosome From
Escherichia Coli At 3.5 A Resolution. This File
Contains The 30s Subunit Of One 70s Ribosome. The
Entire Crystal Structure Contains Two 70s Ribosomes And
Is Described In Remark 400.
pdb|2AW7|O Chain O, Crystal Structure Of The Bacterial Ribosome From
Escherichia Coli At 3.5 A Resolution. This File
Contains The 30s Subunit Of The Second 70s Ribosome.
The Entire Crystal Structure Contains Two 70s Ribosomes
And Is Described In Remark 400.
pdb|1VS5|O Chain O, Crystal Structure Of The Bacterial Ribosome From
Escherichia Coli In Complex With The Antibiotic
Kasugamyin At 3.5a Resolution. This File Contains The
30s Subunit Of One 70s Ribosome. The Entire Crystal
Structure Contains Two 70s Ribosomes And Is Described
In Remark 400.
pdb|1VS7|O Chain O, Crystal Structure Of The Bacterial Ribosome From
Escherichia Coli In Complex With The Antibiotic
Kasugamyin At 3.5a Resolution. This File Contains The
30s Subunit Of One 70s Ribosome. The Entire Crystal
Structure Contains Two 70s Ribosomes And Is Described
In Remark 400.
pdb|2VHO|O Chain O, Structure Of Pdf Binding Helix In Complex With The
Ribosome (Part 3 Of 4)
pdb|2VHP|O Chain O, Structure Of Pdf Binding Helix In Complex With The
Ribosome (Part 4 Of 4)
pdb|3DF1|O Chain O, Crystal Structure Of The Bacterial Ribosome From
Escherichia Coli In Complex With Hygromycin B. This
File Contains The 30s Subunit Of The First 70s
Ribosome, With Hygromycin B Bound. The Entire Crystal
Structure Contains Two 70s Ribosomes.
pdb|3DF3|O Chain O, Crystal Structure Of The Bacterial Ribosome From
Escherichia Coli In Complex With Hygromycin B. This
File Contains The 30s Subunit Of The Second 70s
Ribosome, With Hygromycin B Bound. The Entire Crystal
Structure Contains Two 70s Ribosomes.
pdb|3E1A|H Chain H, Structure Of The 30s Subunit And The Trnas Of E. Coli
Ribosome In Pre- Accommodation State
pdb|3E1C|H Chain H, Structure Of The 30s Subunit And The Trnas Of E. Coli
Ribosome In Post-Accommodation State
pdb|3KC4|O Chain O, Ribosome-Secy Complex. This Entry 3kc4 Contains 30s
Ribosomal Subnit. The 50s Ribosomal Subunit Can Be
Found In Pdb Entry 3kcr
pdb|3IZV|S Chain S, Structural Insights Into Cognate Vs. Near-Cognate
Discrimination During Decoding. This Entry Contains The
Small Subunit Of A Ribosome Programmed With A
Near-Cognate Codon, AT-Site Trna, P-Site Trna, Mrna And
Ef-Tu
pdb|3IZW|S Chain S, Structural Insights Into Cognate Vs. Near-Cognate
Discrimination During Decoding.This Entry Contains The
Small Subunit Of A Ribosome Programmed With A Cognate
Codon, AT-Site Trna, P-Site Trna, Mrna And Ef-Tu
pdb|4ADV|O Chain O, Structure Of The E. Coli Methyltransferase Ksga Bound To
The E. Coli 30s Ribosomal Subunit
Length = 89
Score = 29.6 bits (65), Expect = 5.4, Method: Composition-based stats.
Identities = 23/68 (33%), Positives = 30/68 (44%), Gaps = 11/68 (16%)
Query: 16 ARNYGSRPVQLLRRTLQILVALGSFS-----------LKLLIDQRNGVLDQNKRKRAAEL 64
A + GS VQ+ T QI G F+ L ++ QR +LD KRK A
Sbjct: 19 ANDTGSTEVQVALLTAQINHLQGHFAEHKKDHHSRRGLLRMVSQRRKLLDYLKRKDVARY 78
Query: 65 RRIFTRLG 72
R+ RLG
Sbjct: 79 TRLIERLG 86
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 29.3 bits (64), Expect = 7.1, Method: Compositional matrix adjust.
Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 10/149 (6%)
Query: 142 GQVYKAQLKYSGQIVAVK-VQRPG-IEEAIGLDFYLIRGVGFLINKYVDIITTDVVALID 199
G VYKA+ +SG VA+K V+ P GL +R V L+ + +VV L+D
Sbjct: 23 GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVA-LLRRLEAFEHPNVVRLMD 81
Query: 200 EFA-SRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGVKLNE 258
A SR +E+ ++ + + Y DK P + K L +++ G+
Sbjct: 82 VCATSRTDREIKVTLVFEHVDQDLRTYLDK----APPPGLPAETIKDLMRQFLRGLDFLH 137
Query: 259 QVAI--ENPHPGNLLATPEGKLAFLDFGM 285
I + P N+L T G + DFG+
Sbjct: 138 ANCIVHRDLKPENILVTSGGTVKLADFGL 166
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 28.5 bits (62), Expect = 9.8, Method: Compositional matrix adjust.
Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 29/153 (18%)
Query: 142 GQVYKAQLKYSGQIVAVKVQRPGIEEAIGLDFYLIRGVGFL-------INKYVDIITTDV 194
G VYKA+ K +G++VA+K R E G+ IR + L I K +D+I T+
Sbjct: 20 GVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTE- 77
Query: 195 VALIDEFASRVYQELNYVQEGQNARRFKKLYADKEDVLVPDIFWDYTSGKVLTMEWVEGV 254
+++Y ++ Q+ + F A + +P I K + ++G+
Sbjct: 78 --------NKLYLVFEFLH--QDLKTFMDASA-LTGIPLPLI-------KSYLFQLLQGL 119
Query: 255 KL--NEQVAIENPHPGNLLATPEGKLAFLDFGM 285
+ +V + P NLL EG + DFG+
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 152
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.322 0.139 0.403
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 15,216,123
Number of Sequences: 62578
Number of extensions: 615438
Number of successful extensions: 1575
Number of sequences better than 100.0: 81
Number of HSP's better than 100.0 without gapping: 1
Number of HSP's successfully gapped in prelim test: 80
Number of HSP's that attempted gapping in prelim test: 1539
Number of HSP's gapped (non-prelim): 85
length of query: 593
length of database: 14,973,337
effective HSP length: 104
effective length of query: 489
effective length of database: 8,465,225
effective search space: 4139495025
effective search space used: 4139495025
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 54 (25.4 bits)